Cover Image
市場調查報告書

醫藥品的南美市場展望:2015-2025年

Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs

出版商 Visiongain Ltd 商品編碼 339861
出版日期 內容資訊 英文 150 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫藥品的南美市場展望:2015-2025年 Latin American Pharmaceutical Market Outlook 2018-2028: Brazil, Mexico, Venezuela, Argentina, Colombia, Chile, Rest of Latin America, Generics, OTC, Biosimilars, Originator Drugs
出版日期: 2017年10月19日 內容資訊: 英文 150 Pages
簡介

南美的醫藥品市場收益,預計2018年達到872億9,000萬美元,到2025年穩定收益成長。

本報告提供南美的醫藥品市場相關調查、南美市場收益的預測、主要國家市場收益預測、南美整體經濟狀況、市場促進成長要素與阻礙要素,及南美的醫藥品的前五名公司相關分析。

第1章 報告概要

第2章 南美的醫藥品市場:簡介

  • 全球醫藥品市場:簡介
  • 南美的醫藥品市場
  • 地區的貿易團體、政府間組織

第3章 南美的醫藥品市場

  • 南美的醫藥品市場預測
  • 南美的醫藥品市場影響因素
    • 人口增加、高齡化
    • 經濟狀況
    • TPP (環太平洋夥伴關係協定)
  • 南美的醫藥品市場分析
    • 學名藥市場預測
    • OTC市場預測
    • 生技仿製藥市場預測
    • 首發醫藥品市場預測
  • 南美的醫藥品市場SWOT分析
    • 優勢
    • 弱點
    • 機會
    • 威脅

第4章 南美的主要國家市場

  • 南美的主要國家市場
  • 南美的主要國家的醫藥品市場
  • 南美的醫藥品市場上主要國家的市場佔有率

第5章 巴西的醫藥品市場

  • 醫藥品市場
  • 醫藥品次市場
    • 學名藥市場預測
    • OTC市場預測
    • 生技仿製藥市場預測
    • 首發醫藥品市場預測
  • 醫藥品次市場預測

第6章 墨西哥的醫藥品市場

第7章 委內瑞拉的醫藥品市場

第8章 阿根廷的醫藥品市場

第9章 哥倫比亞的醫藥品市場

第10章 智利的醫藥品市場

第11章 南美的其他的醫藥品市場

第12章 南美的醫藥品的前五名公司

  • Sanofi S.A
  • EMS S.A
  • Novarits
  • Pfizer
  • Bayer

第13章 結論

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0249

The Latin American Pharmaceutical Market is expected to grow at a CAGR of 9.3% in the first half of the forecast period. In 2017, the Brazilian Pharmaceutical market accounted for 35.1% of the Latin American Pharmaceutical market.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 150-page report you will receive 69 tables and 60 figures- all unavailable elsewhere.

The 150-page report provides clear detailed insight into the Latin American Pharmaceutical Market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

  • Latin American Pharmaceutical Market forecasts from 2018-2028
  • This report also breaks down the revenue forecast for the Latin American Pharmaceutical Market by Submarket:
    • Generics
    • OTC
    • Biosimilars
    • Originator Drugs
  • This report also breaks down the revenue forecast for the Latin American Pharmaceutical Market by Country:
    • Brazil
    • Mexico
    • Venezuela
    • Argentina
    • Colombia
    • Chile
    • Rest of Latin America

image1

Each country is further segmented into Generics, OTC, Biosimilars and Originator Drugs.

  • Our study provides a SWOT Analysis of the Latin American Pharmaceutical Market.
  • Our study discusses the selected leading companies that are the major players in the Latin American Pharmaceutical Market:
    • Pfizer
    • Bayer
    • Sanofi
    • Novartis
    • EMS

Visiongain's study is intended for anyone requiring commercial analyses for the Latin American Pharmaceutical Market. You find data, trends and predictions.

Table of Contents

1. Report Overview

  • 1.1 Latin American Pharmaceutical Market: Overview
  • 1.2 Latin American Pharmaceutical Market Segmentation
  • 1.3 Why You Should Read This Report
  • 1.4 How This Report Delivers
  • 1.5 Main Questions Answered by This Study
  • 1.6 Who is This Investigation For?
  • 1.7 Research and Analysis Methods
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Some Associated Reports
  • 1.10 About Visiongain

2. Introduction to the Latin American Pharmaceutical Market

  • 2.1 Introduction to the Global Pharmaceutical Market
  • 2.2 The Latin American Pharmaceutical Market 2017
    • 2.2.1 Definition of Latin America
    • 2.2.2 Regional Trade Bodies and Intergovernmental Organisations
      • 2.2.2.1 Mercado Comün del Sur/Mercado Comum do Sul (Mercosur)
      • 2.2.2.2 The Andean Community (CAN)
      • 2.2.2.3 The Union of South American Nations (USAN)
      • 2.2.2.4 The Pacific Alliance
      • 2.2.2.5 Bolivarian Alliance for the Peoples of Our America (ALBA)

3. The Latin American Pharmaceutical Market, 2018-2028

  • 3.1 The Latin American Pharmaceutical Market Forecast, 2018-2028
  • 3.2 Factors Affecting the Latin American Pharmaceutical Market
    • 3.2.1 Population Growth and Ageing
    • 3.2.2 Economic Conditions
    • 3.2.3 Trans-Pacific Partnership (TPP)
  • 3.3 The Latin American Pharmaceutical Market Breakdown, 2018-2028
    • 3.3.1 The Latin American Generic Drugs Market Forecast, 2018-2028
    • 3.3.2 The Latin American OTC Market Forecast, 2018-2028
    • 3.3.3 The Latin American Biosimilars Market Forecast, 2018-2028
    • 3.3.4 Latin American Originator Drugs Market Forecast, 2018-2028
  • 3.4 SWOT Analysis of the Latin American Pharmaceutical Market, 2018-2028
    • 3.4.1 Strengths
      • 3.4.1.1 One of the Quickest Growing Markets Globally
      • 3.4.1.2 Increasing Incidence of Chronic Diseases
      • 3.4.1.3 Ageing Population
      • 3.4.1.4 Increasing Investment in Health Care Systems
    • 3.4.2 Weaknesses
      • 3.4.2.1 Poor Economic Performance and Devalued Currencies
      • 3.4.2.2 Weak Regulation
      • 3.4.2.3 Weak IP Protection
    • 3.4.3 Opportunities
      • 3.4.3.1 Emerging Biosimilars Market
      • 3.4.3.2 Regional Pharmaceutical Companies Could Expand Outside Latin America
      • 3.4.3.3 Increased Trade Liberalisation Could Open More Markets
    • 3.4.4 Threats
      • 3.4.4.1 Pharmaceutical Companies from Other Emerging Markets Could Challenge Regional Firms
      • 3.4.4.2 Increased Protectionist Measures Could Severely Harm the Industry
      • 3.4.4.3 Further Economic Problems and Currency Devaluations Possible

4. Latin American National Markets, 2018-2028

  • 4.1 Latin American National Markets, 2017
  • 4.2 Latin American National Pharmaceutical Market Forecasts, 2018-2028
  • 4.3 Leading National Markets Shares of the Latin American Pharmaceutical Market
    • 4.3.1 Leading National Markets Shares of the Latin American Pharmaceutical Market, 2017
    • 4.3.2 Leading National Markets Shares of the Latin American Pharmaceutical Market, 2023
    • 4.3.3 Leading National Markets Shares of the Latin American Pharmaceutical Market, 2028

5. The Brazilian National Pharmaceutical Market, 2018-2028

  • 5.1 The Brazilian National Pharmaceutical Market, 2017
  • 5.2 The Brazilian National Pharmaceutical Sub-Market Forecasts, 2018-2028
    • 5.2.1 The Brazilian National Pharmaceutical Market Forecast, 2018-2028
    • 5.2.2The Brazilian Generic Drugs Market Forecast, 2018-2028
    • 5.2.3 The Brazilian OTC Market Forecast, 2018-2028
    • 5.2.4 The Brazilian Biosimilars Market Forecast, 2018-2028
    • 5.2.5 The Brazilian Originator Drugs Market Forecast, 2018-2028
  • 5.3 The Brazilian National Pharmaceutical - Current Currency Fluctuations

6. The Mexican National Pharmaceutical Market, 2018-2028

  • 6.1 The Mexican National Pharmaceutical Market, 2017
  • 6.2 The Mexican National Pharmaceutical Sub-Market Forecasts, 2018-2028
    • 6.2.1 The Mexican National Pharmaceutical Market Forecast, 2018-2028
    • 6.2.2 The Mexican Generic Drugs Market Forecast, 2018-2028
    • 6.2.3 The Mexican OTC Market Forecast, 2018-2028
    • 6.2.4 The Mexican Biosimilars Market Forecast, 2018-2028
    • 6.2.5 The Mexican Originator Drugs Market Forecast, 2018-2028

7. The Venezuelan National Pharmaceutical Market, 2018-2028

  • 7.1 The Venezuelan National Pharmaceutical Market, 2018
  • 7.2 The Venezuelan National Pharmaceutical Market Breakdown Forecast, 2018-2028
    • 7.2.1 The Venezuelan National Pharmaceutical Market Forecast, 2018-2028
    • 7.2.2 The Venezuelan Generic Drugs Market Forecast, 2018-2028
    • 7.2.3 The Venezuelan OTC Market Forecast, 2018-2028
    • 7.2.4 The Venezuelan Biosimilars Market Forecast, 2018-2028
    • 7.2.5 The Venezuelan Originator Drugs Market Forecast, 2018-2028

8. The Argentine National Pharmaceutical Market, 2018-2028

  • 8.1 The Argentine National Pharmaceutical Market, 2017
  • 8.2 The Argentine National Pharmaceutical Market Breakdown, 2018-2028
    • 8.2.1 The Argentine National Pharmaceutical Market Forecast, 2018-2028
    • 8.2.2 The Argentine Generic Drugs Market Forecast, 2018-2028
    • 8.2.3 The Argentine OTC Market Forecast, 2018-2028
    • 8.2.4 The Argentine Biosimilars Market Forecast, 2018-2028
    • 8.2.5 The Argentine Originator Drugs Market Forecast, 2018-2028

9. The Colombian National Pharmaceutical Market, 2018-2028

  • 9.1 The Colombian National Pharmaceutical Market, 2017
  • 9.2 The Colombian National Pharmaceutical Market Breakdown, 2018-2028
    • 9.2.1 The Colombian National Pharmaceutical Market Forecast, 2018-2028
      • 9.2.1.1 Economic Growth and Financial Constraints
      • 9.2.1.2 Introduction of the Statutory Health Law
    • 9.2.2 The Colombian Generic Drugs Market Forecast, 2018-2028
    • 9.2.3 The Colombian OTC Market Forecast, 2018-2028
    • 9.2.4 The Colombian Biosimilars Market Forecast, 2018-2028
    • 9.2.5 The Colombian Originator Drugs Market Forecast, 2018-2028

10. The Chilean National Pharmaceutical Market, 2018-2028

  • 10.1 The Chilean National Pharmaceutical Market, 2018
    • 10.1.1 The Chilean Health Care System
    • 10.1.2 Majority of Generic Revenue from Branded Generics
  • 10.2 The Chilean National Pharmaceutical Market Breakdown, 2018-2028
    • 10.2.1 The Chilean National Pharmaceutical Market Forecast, 2018-2028
    • 10.2.2 The Chilean Generic Drugs Market Forecast, 2018-2028
    • 10.2.3 The Chilean OTC Market Forecast, 2018-2028
    • 10.2.4 The Chilean Biosimilars Market Forecast, 2018-2028
    • 10.2.5 The Chilean Originator Drugs Market Forecast, 2018-2028

11. The Rest of the Latin American Pharmaceutical Market, 2018-2028

  • 11.1 The Rest of the Latin American Pharmaceutical Market, 2017
  • 11.2 The Rest of the Latin American Pharmaceutical Market Breakdown, 2018-2028

12. Top Five Pharmaceutical Companies in Latin America

  • 12.1 Bayer AG
    • 12.1.1 Bayer AG: Company Overview
    • 12.1.2 Bayer AG: Product Portfolio
    • 12.1.3 Bayer AG: Recent Developments
  • 12.2 Pfizer Inc.
    • 12.2.1 Pfizer Inc.: Company Overview
    • 12.2.2 Pfizer Inc.: Product Portfolio
  • 12.3 Sanofi S.A.
    • 12.3.1 Sanofi S.A.: Company Overview
    • 12.3.2 Sanofi S.A.: Product Portfolio
    • 12.3.3 Sanofi S.A: Recent Developments
  • 12.4 Novartis AG
    • 12.4.1 Novartis AG: Company Overview
    • 12.4.2 Novartis AG: Product Portfolio
  • 12.5 EMS SA
    • 12.5.1 EMS SA: Company Overview

13. Conclusions

  • 13.1 The Latin American Pharmaceutical Market, 2017-2018
  • 13.2 Latin American Pharmaceutical Market Forecast, 2018-2028

Appendices

  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • About Visiongain
  • Visiongain Report Evaluation Form

List of Tables

  • Table 2.1 Market Share (%) of the Global Pharmaceutical Market by Region, 2017
  • Table 2.2 Population Sizes of Latin American Countries/Regions and Percentage of Total Population (%), 2017
  • Table 3.1 The Latin American Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 3.2 Percentage (%) of Population Over 65 Years Old in Key Latin American Markets and Segment Average, 2010 and 2050
  • Table 3.3 The Latin American Pharmaceutical Market Breakdown by Submarket, Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 3.4 The Latin American Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 3.5 The Latin American OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 3.6 The Latin American Biosimilars Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 3.7 The Latin American Originator Drugs Market: Revenue($bn), AGR (%) and CAGR (%), 2018-2027
  • Table 3.8 SWOT Analysis of the Latin American Pharmaceutical Market, 2018-2028
  • Table 4.1 Market Revenues ($bn) of the Six Largest Pharmaceutical Markets in Latin America, 2017
  • Table 4.2 The Latin American National Pharmaceutical Market by Country: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 4.3 National Market Revenues ($bn) and Latin American Market Shares (%) by Country, 2017
  • Table 4.4 National Market Revenues ($bn) and Latin American Market Shares (%), 2023
  • Table 4.5 National Market Revenues ($bn) and Latin American Market Shares (%), 2028
  • Table 5.1 Brazilian National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.2 Brazilian National Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.3 Brazilian Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.4 Brazilian OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.5 Brazilian Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 5.6 Brazilian Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 6.1 Mexican National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 6.2 Mexican National Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 6.3 Mexican Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 6.4 Mexican OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 6.5 Mexican Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 6.6 Mexican Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 7.1 Venezuelan National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 7.2 Venezuelan National Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 7.3 Venezuelan Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 7.4 Venezuelan OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 7.5 Venezuelan Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 7.6 Venezuelan Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 8.1 Argentine National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 8.2 Argentine National Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 8.3 Argentine Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 8.4 Argentine OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 8.5 Argentine Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 8.6 Argentine Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 9.1 Colombian National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 9.2 Colombian National Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 9.3 Colombian Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 9.4 Colombian OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 9.5 Colombian Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 9.6 Colombian Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 10.1 Branded Market Share (%) of Generic Drugs Market by Value, 2017
  • Table 10.2 Chilean National Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 10.3 Chilean National Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 10.4 Chilean Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 10.5 Chilean OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 10.6 Chilean Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 10.7 Chilean Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 11.1 The Rest of the Latin American Pharmaceutical Market Breakdown by Submarket: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 11.2 Rest of the Latin American Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 11.3 Rest of the Latin American Generic Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 11.4 Rest of the Latin American OTC Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 11.5 Rest of the Latin American Biosimilars Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 11.6 Rest of the Latin American Originator Drugs Market: Revenue ($bn), AGR (%) and CAGR (%), 2018-2028
  • Table 12.1 Bayer AG: Company Overview
  • Table 12.2 Bayer AG: Product Portfolio
  • Table 12.3 Bayer AG: Recent Developments
  • Table 12.4 Pfizer Inc.: Company Overview
  • Table 12.5 Pfizer Inc.: Product Portfolio
  • Table 12.6 Sanofi S.A.: Company Overview
  • Table 12.7 Novartis AG: Company Overview
  • Table 12.8 Novartis AG: Product Portfolio
  • Table 12.9 EMS SA: Company Overview
  • Table 13.1 The Latin American National Pharmaceutical Markets: Revenue ($bn), 2017-2018
  • Table 13.2 The Latin American Pharmaceutical Market: Revenue ($bn), AGR (%), CAGR (%), 2017-2028

List of Figures

  • Figure 1.2 Key Markets within the Latin American Pharmaceutical Market
  • Figure 1.3 Key Product Types within the Latin American Pharmaceutical Market
  • Figure 2.1 Market Shares (%) of Pharmaceutical Market by Region, 2017
  • Figure 2.2 Population Sizes of Latin American Countries/Regions by Percentage (%), 2017
  • Figure 3.1 The Latin American Pharmaceutical Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 3.2 The Latin American Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 3.3 The Latin American OTC Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 3.4 The Latin American Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 3.5 The Latin American Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 4.1 Market Revenues ($bn) of Six Largest Pharmaceutical Markets in Latin America plus Rest of Latin America, 2017
  • Figure 5.1 Brazilian National Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.2 Brazilian Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.3 Brazilian OTC Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.4 Brazilian Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 5.5 Brazilian Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 6.1 Mexican National Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 6.2 Mexican Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 6.3 Mexican OTC Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 6.4 Mexican Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 6.5 Mexican Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 7.1 Venezuelan National Pharmaceutical Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 7.2 Venezuelan Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 7.3 Venezuelan OTC Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 7.4 Venezuelan Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 7.5 Venezuelan Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 8.1 Argentine National Pharmaceutical Market: Revenue($bn) and AGR (%), 2018-2028
  • Figure 8.2 Argentine Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 8.3 Argentine OTC Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 8.4 Argentine Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 8.5 Argentine Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 9.1 Colombian National Pharmaceutical Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 9.2 Colombian Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 9.3 Colombian OTC Market: Revenue($bn) and AGR (%), 2018-2028
  • Figure 9.4 Colombian Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 9.5 Colombian Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 10.1 Branded Market Share (%) of Generic Drugs Market by Value, 2017
  • Figure 10.2 Chilean National Pharmaceutical Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 10.3 Chilean Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 10.4 Chilean OTC Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 10.5 Chilean Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 10.6 Chilean Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 11.1 Rest of the Latin American National Pharmaceutical Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 11.2 Rest of the Latin American Generic Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 11.3 Rest of the Latin American OTC Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 11.4 Rest of the Latin American Biosimilars Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 11.5 Rest of the Latin American Originator Drugs Market: Revenue ($bn) and AGR (%), 2018-2028
  • Figure 12.1 Bayer AG, Revenue, ($million), 2012-2016
  • Figure 12.2 Bayer AG, Product Segments Share (%), 2016
  • Figure 12.3 Bayer AG, Geographic Presence Share (%), 2016
  • Figure 12.4 Pfizer Inc., Revenue, ($million), 2012-2016
  • Figure 12.5 Pfizer Inc., Product Segments Share (%), 2016
  • Figure 12.6 Pfizer Inc., Geographical Presence Share (%), 2016
  • Figure 12.7 Sanofi S.A., Revenue, ($million), 2012-2016
  • Figure 12.8 Sanofi S.A., Product Segments Share (%), 2016
  • Figure 12.9 Sanofi S.A., Geographical Presence Share (%), 2016
  • Figure 12.10 Novartis AG, Revenue, ($million), 2012-2016
  • Figure 12.11 Novartis AG, Product Segments Share (%), 2016
  • Figure 12.12 Novartis AG, Geographical Presence Share (%), 2016
  • Figure 13.1 The Latin American National Pharmaceutical Markets: Revenue ($bn), 2017-2018
  • Figure 13.2 The Latin American Pharmaceutical Market: Revenue ($bn), 2017-2028

Companies Listed

  • Abbott Laboratories
  • Aspen Pharmaceuticals
  • Bago
  • Bayer AG
  • Bioceres
  • Biocon
  • Celltrion
  • CFR Pharmaceuticals
  • Ciba-Geigy
  • EMS S.A
  • Genfar
  • Germed
  • GlaxoSmithKline
  • Hospira
  • Janssen RA
  • Laboratorio Teuto Brasileiro.
  • Laboratorios Bernabo
  • Laboratorios Kendrick
  • LaFrancol
  • LeGrand
  • Medley
  • Merck AG
  • Merial S.A.S.
  • Merial, Inc.
  • Novartis
  • NC Participações S.A.
  • Orygen
  • Pemex
  • Pfizer
  • Priobiomed
  • Roemmers
  • Sandoz
  • Sanofi S.A
  • Shanghai CP Goujian
  • Takeda

List of Organizations Mentioned in the Report

  • Bolivarian Alliance for the Peoples of Our America (ALBA)
  • Brazilian Ministry of Health
  • Brazilian Unified Health System
  • Chilean Institute of Public Health
  • COFEPRIS
  • Instituto de Seguridad y Servicios Sociales de los Trabajadoes del Estad (ISSSTE)
  • Instituto Mexicano del Seguro Social (IMSS)
  • Instituto Venezolano de los Seguros Sociales (IVSS)
  • Mercosur
  • National Drugs Agency (ANAMED)
  • Pan American Health Organisation
  • Sistema General de Seguridad Social en Salud
  • The Andean Community (CAN)
  • The Pacific Alliance
  • The Union of South American Nations (USAN)
  • Trans-Pacific Partnership
  • United Nations Department of Economic and Social Affairs
  • Venezuelan Ministry of Popular Power for Health
Back to Top